(Q44260190)

1 December 2017

title

Pentosidine and N(epsilon)-(carboxymethyl)-lysine in Alzheimer's disease and vascular dementia (English)

1 reference

1 December 2017

0 references

0 references

K J Bär

1

1 reference

1 December 2017

S Franke

2

1 reference

1 December 2017

B Wenda

3

1 reference

1 December 2017

S Müller

4

1 reference

1 December 2017

R Kientsch-Engel

5

1 reference

1 December 2017

G Stein

6

1 reference

1 December 2017

H Sauer

7

1 reference

1 December 2017

publication date

1 March 2003

1 reference

1 December 2017

published in

Neurobiology of Aging

1 reference

1 December 2017

volume

24

1 reference

1 December 2017

issue

2

1 reference

1 December 2017

page(s)

333-338

1 reference

Assessment of cognitive impairment: relationship of the Dementia Rating Scale to the Mini-Mental State Examination

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Lipid advanced glycosylation: pathway for lipid oxidation in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Active glycation in neurofibrillary pathology of Alzheimer disease: N(epsilon)-(carboxymethyl) lysine and hexitol-lysine

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Oxidized proteins in Alzheimer's plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

1 reference

7 January 2021

Immunochemical detection of imidazolone in uremia and rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

The advanced glycation end product, Nepsilon-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Apolipoprotein E polymorphism in patients with Alzheimer's disease, vascular dementia and ischemic cerebrovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Accumulation of advanced glycation end products of the Maillard reaction with age in human hippocampal neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Localization of identified advanced glycation end-product structures, N epsilon(carboxymethyl)lysine and pentosidine, in age-related inclusions in human brains

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Oxidative stress hypothesis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Increased Pentosidine, an Advanced Glycation End Product, in Plasma and Synovial Fluid from Patients with Rheumatoid Arthritis and Its Relation with Inflammatory Markers

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Advanced glycation endproducts are associated with Hirano bodies in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Influence of advanced glycation end-products and AGE-inhibitors on nucleation-dependent polymerization of β-amyloid peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Alzheimer's disease--synergistic effects of glucose deficit, oxidative stress and advanced glycation endproducts

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Advanced glycation endproducts in ageing and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Apoptosis in neural development and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Early glycoxidation damage in brains from Down's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Lipoperoxidation is selectively involved in progressive supranuclear palsy

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Psychometrics in aging and dementia: advances in geropsychological assessments

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Psychometrics in the treatment of ischemic cerebrovascular diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Oxidative stress, antioxidants, and Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Advanced glycation end products in Alzheimer's disease and other neurodegenerative diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Increased accumulation of the glycoxidation product N(epsilon)-(carboxymethyl)lysine in human tissues in diabetes and aging.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Evidence against increased glycoxidation in patients with Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Increased protein glycation in cerebrospinal fluid of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Advanced glycation end-products: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Advanced Maillard reaction end products are associated with Alzheimer disease pathology

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Lipoprotein(a), apolipoprotein E genotype, and risk of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Relationship between pentosidine levels in serum and urine and activity in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Advanced glycation end products co-localized with astrocytes and microglial cells in Alzheimer's disease brain

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Lipoprotein(a) phenotypes in patients with vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

New biomarkers of Maillard reaction damage to proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

Cellular cofactors potentiating induction of stress and cytotoxicity by amyloid beta-peptide

1 reference

https://api.crossref.org/works/10.1016%2FS0197-4580%2802%2900086-6

7 January 2021

10.1016/S0197-4580(02)00086-6

Identifiers

DOI

1 reference

release_hwbah3shzvbgzfznztuhvk4iii

1 December 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hwbah3shzvbgzfznztuhvk4iii

24 November 2022

mapped directly with Wikidata item

1 reference